Quick Answer
Traws Pharma, Inc. reported Total Revenue of $226.0 thousand for fiscal year 2024.
Traws Pharma, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $226.0K | +0.0% |
| 2023 | $226.0K | +0.0% |
| 2022 | $226.0K | +0.0% |
| 2021 | $226.0K | -2.2% |
| 2020 | $231.0K | -89.4% |
| 2019 | $2.18M | +77.8% |
| 2018 | $1.23M | +56.0% |
| 2017 | $787.0K | -85.8% |
| 2016 | $5.55M | -51.6% |
| 2015 | $11.46M | +1332.0% |
| 2014 | $800.0K | -83.2% |
| 2013 | $4.75M | -89.7% |
| 2012 | $46.19M | +3006.3% |
| 2011 | $1.49M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | $2.73M | +4694.7% | +4694.7% |
| March 31, 2025 | $57.0K | +1.8% | +0.0% |
| September 30, 2024 | $57.0K | +0.0% | +0.0% |
| June 30, 2024 | $57.0K | +0.0% | +1.8% |
| March 31, 2024 | $56.0K | +0.0% | -1.8% |
| September 30, 2023 | $57.0K | +0.0% | +0.0% |
| June 30, 2023 | $57.0K | +0.0% | +1.8% |
| March 31, 2023 | $56.0K | +0.0% | -1.8% |
- Traws Pharma, Inc. showed an increase of +0.0% in Total Revenue compared to the prior fiscal year.
- Over the 2011–2024 period, Traws Pharma, Inc.’s total revenue has declined by 84.8% (from $1.49 million to $226.0 thousand).
- The most recent figure is from Traws Pharma, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: